Harnessing the Power of Artificial Intelligence for Enhanced Point-of-Care Quality Control in Healthcare.

Improving Healthcare Quality Control: A Comprehensive Review on Harnessing Artificial Intelligence for Point-of-Care Enhancement

Authors

  • NGNOTOUOM NGNOKAM TANIA CYRIELLE Department of General Medicine, Université Evangélique en Afrique, Democratic Republic of Congo
  • ANGYIBA SERGE ANDIGEMA Department of Research and Education, Oli Health Magazine Organization, Kigali, Rwanda
  • MAFO KAMGA Lethicia Danaëlle Department of Microbiology, Immunology and Hematology; Faculty of medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon
  • EWANE Ekwelle Department of Electronics and Electrical Engineering, College of Technology, University of Buea.

DOI:

https://doi.org/10.32896/ajmedtech.v4n1.22-33

Keywords:

Artificial Intelligence, Quality control, Point-of-Care, Diagnosis, infectious diseases

Abstract

Artificial intelligence (AI) is increasingly being used to improve the quality control of point-of-care diagnostics. This is caused by a number of factors, including the following: 1. AI can accelerate and improve testing accuracy. In comparison to humans, AI technology can review data more quickly and precisely, reducing errors and improving overall quality assurance. 2. When it comes to improving POC test findings on healthcare issues such as infectious diseases or medical crises such as heart attacks, AI can be used for sophisticated predictive analytics and modeling that aid in better decision-making. 3. Artificial intelligence facilitates process automation, increasing productivity and lowering labor costs in labor-intensive tasks such as testing and analyzing samples collected at point-of-care facilities. 4. The use of AI enables organizations implementing these solutions to gain insights from large volumes of raw diagnostic data generated faster and more accurately, allowing them to build solid frameworks around preventive care initiatives and significantly influence public health outcomes.5. Artificial intelligence (AI) has been demonstrated to be a useful tool for real-time monitoring systems that identify any problems with test results early so that they can be corrected before affected patients receive inaccurate diagnoses or treatment plans based on false information provided by diagnostic tests performed at points of care such as clinics or hospitals.

Using these technologies would allow healthcare organizations to spend less on labor while still receiving exact diagnoses and rapid treatment delivery at a fraction of the cost that manual approaches required earlier.

References

S. S. Chanda and D. N. Banerjee, “Omission and commission errors underlying AI failures,” AI & Soc., pp. 1–24, 2022.

A. S. Andigema, N. N. T. Cyrielle, K. P. Landry, and A. J. Vladimir, “AI in the Management of HIV: Case Study Cameroon,” Int J Virol AIDS, vol. 10, p. 89, 2023.

Z. Zhao and D. B. Sacks, “Assay Development in Clinical Pathology,” in Pathobiology of Human Disease, L. M. McManus and R. N. Mitchell, Eds. San Diego: Academic Press, 2014, pp. 3194–3206. doi: https://doi.org/10.1016/B978-0-12-386456-7.06301-2.

Quality Assurance. (2024) PubMed. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/32491435/

S. Nayak, N. R. Blumenfeld, T. Laksanasopin, and S. K. Sia, “Point-of-care diagnostics: recent developments in a connected age,” Anal. Chem., vol. 89, no. 1, pp. 102–123, 2017.

M. Martinelli, D. Moroni, A. Prochazka, and M. Strojnik, “Artificial intelligence in point of care diagnostics,” Front. Digit. Heal., vol. 5, p. 1236178, 2023.

Larkins, M. C. (2023). Point-of-Care Testing. StatPearls - NCBI Bookshelf. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK592387/

G. Krishnan et al., “Artificial intelligence in clinical medicine: catalyzing a sustainable global healthcare paradigm,” Front. Artif. Intell., vol. 6, 2023.

N. Ghaffar Nia, E. Kaplanoglu, and A. Nasab, “Evaluation of artificial intelligence techniques in disease diagnosis and prediction,” Discov. Artif. Intell., vol. 3, no. 1, p. 5, 2023.

K. C. H. Tsang, H. Pinnock, A. M. Wilson, and S. A. Shah, “Application of machine learning algorithms for asthma management with mHealth: a clinical review,” J. Asthma Allergy, pp. 855–873, 2022.

M. M. Ahsan, S. A. Luna, and Z. Siddique, “Machine-learning-based disease diagnosis: A comprehensive review,” in Healthcare, 2022, vol. 10, no. 3, p. 541.

M. M. Ahsan, S. A. Luna, and Z. Siddique, “Machine-learning-based disease diagnosis: A comprehensive review,” in Healthcare, 2022, vol. 10, no. 3, p. 541.

R. P. Salongcay et al., “Accuracy of Integrated Artificial Intelligence Grading Using Handheld Retinal Imaging in a Community Diabetic Eye Screening Program,” Ophthalmol. Sci., vol. 4, no. 3, p. 100457, 2024.

B. Sheng et al., “An overview of artificial intelligence in diabetic retinopathy and other ocular diseases,” Front. Public Heal., vol. 10, p. 971943, 2022.

V. Turbé et al., “Deep learning of HIV field-based rapid tests,” Nat. Med., vol. 27, no. 7, pp. 1165–1170, 2021.

R. J. Ward et al., “Flunet: An ai-enabled influenza-like warning system,” IEEE Sens. J., vol. 21, no. 21, pp. 24740–24748, 2021.

N. Melarkode, K. Srinivasan, S. M. Qaisar, and P. Plawiak, “AI-powered diagnosis of skin cancer: a contemporary review, open challenges and future research directions,” Cancers (Basel)., vol. 15, no. 4, p. 1183, 2023.

H. Zhang et al., “Artificial intelligence for the prediction of acute kidney injury during the perioperative period: systematic review and Meta-analysis of diagnostic test accuracy,” BMC Nephrol., vol. 23, no. 1, p. 405, 2022.

O. Hrizi et al., “Tuberculosis disease diagnosis based on an optimized machine learning model,” J. Healthc. Eng., vol. 2022, 2022.

A. Bohr and K. Memarzadeh, “Chapter 2 - The rise of artificial intelligence in healthcare applications,” in Artificial Intelligence in Healthcare, A. Bohr and K. Memarzadeh, Eds. Academic Press, 2020, pp. 25–60. doi: https://doi.org/10.1016/B978-0-12-818438-7.00002-2.

B. Heidt et al., “Point of care diagnostics in resource-limited settings: A review of the present and future of PoC in its most needed environment,” Biosensors, vol. 10, no. 10, p. 133, 2020.

D. B. Larson, H. Harvey, D. L. Rubin, N. Irani, R. T. Justin, and C. P. Langlotz, “Regulatory frameworks for development and evaluation of artificial intelligence--based diagnostic imaging algorithms: summary and recommendations,” J. Am. Coll. Radiol., vol. 18, no. 3, pp. 413–424, 2021.

D. D. Farhud and S. Zokaei, “Ethical issues of artificial intelligence in medicine and healthcare,” Iran. J. Public Health, vol. 50, no. 11, p. i, 2021.

N. Khalid, A. Qayyum, M. Bilal, A. Al-Fuqaha, and J. Qadir, “Privacy-preserving artificial intelligence in healthcare: Techniques and applications,” Comput. Biol. Med., p. 106848, 2023.

H. S. Yang, D. D. Rhoads, J. Sepulveda, C. Zang, A. Chadburn, and F. Wang, “Building the model: challenges and considerations of developing and implementing machine learning tools for clinical laboratory medicine practice,” Arch. Pathol. & Lab. Med., vol. 147, no. 7, pp. 826–836, 2023.

Published

2024-05-31

How to Cite

TANIA CYRIELLE, N. N., SERGE ANDIGEMA, A., Lethicia Danaëlle, M. K., & Ekwelle, E. (2024). Harnessing the Power of Artificial Intelligence for Enhanced Point-of-Care Quality Control in Healthcare.: Improving Healthcare Quality Control: A Comprehensive Review on Harnessing Artificial Intelligence for Point-of-Care Enhancement. Asian Journal Of Medical Technology, 4(1), 22–33. https://doi.org/10.32896/ajmedtech.v4n1.22-33